These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25238820)

  • 41. Omega 3 fatty acids and inborn errors of metabolism.
    Gil-Campos M; Sanjurjo Crespo P
    Br J Nutr; 2012 Jun; 107 Suppl 2():S129-36. PubMed ID: 22591887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
    Cederholm T; Palmblad J
    Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index.
    Hooper C; De Souto Barreto P; Coley N; Cantet C; Cesari M; Andrieu S; Vellas B
    J Nutr Health Aging; 2017; 21(9):988-993. PubMed ID: 29083439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diet, cognition, and Alzheimer's disease: food for thought.
    Otaegui-Arrazola A; Amiano P; Elbusto A; Urdaneta E; Martínez-Lage P
    Eur J Nutr; 2014 Feb; 53(1):1-23. PubMed ID: 23892520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omega-3 fatty acids and risk of cognitive impairment and dementia.
    Laurin D; Verreault R; Lindsay J; Dewailly E; Holub BJ
    J Alzheimers Dis; 2003 Aug; 5(4):315-22. PubMed ID: 14624027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020.
    Giudici KV
    J Prev Alzheimers Dis; 2021; 8(2):118-122. PubMed ID: 33569556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ω-3 fatty acids on cognitive performance: a meta-analysis.
    Mazereeuw G; Lanctôt KL; Chau SA; Swardfager W; Herrmann N
    Neurobiol Aging; 2012 Jul; 33(7):1482.e17-29. PubMed ID: 22305186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.
    Oulhaj A; Jernerén F; Refsum H; Smith AD; de Jager CA
    J Alzheimers Dis; 2016; 50(2):547-57. PubMed ID: 26757190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence.
    Loef M; Walach H
    J Nutr Gerontol Geriatr; 2013; 32(1):1-23. PubMed ID: 23451843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis.
    Alex A; Abbott KA; McEvoy M; Schofield PW; Garg ML
    Nutr Rev; 2020 Jul; 78(7):563-578. PubMed ID: 31841161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary omega-3 fatty acids for women.
    Bourre JM
    Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary Sources of Omega-3 Fatty Acids Versus Omega-3 Fatty Acid Supplementation Effects on Cognition and Inflammation.
    Singh JE
    Curr Nutr Rep; 2020 Sep; 9(3):264-277. PubMed ID: 32621236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
    Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B;
    Maturitas; 2020 Nov; 141():39-45. PubMed ID: 33036701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
    Pauwels EK; Volterrani D; Mariani G; Kairemo K
    Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. n-3 Fatty acids, Mediterranean diet and cognitive function in normal aging: A systematic review.
    Masana MF; Koyanagi A; Haro JM; Tyrovolas S
    Exp Gerontol; 2017 May; 91():39-50. PubMed ID: 28213052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-3 Polyunsaturated Fatty Acids in Elderly with Mild Cognitive Impairment: A Systemic Review and Meta-Analysis.
    Yang L; Zhao F; Sun Y; Wang Z; Li Q; Wang H; Lu Y
    J Alzheimers Dis; 2024; 99(s1):S81-S95. PubMed ID: 36776054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship of Omega 3 Polyunsaturated Fatty Acids in Red Blood Cell Membranes with Cognitive Function and Brain Structure: A Review Focussed on Alzheimer's Disease.
    Hooper C; De Souto Barreto P; Pahor M; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2018; 5(1):78-84. PubMed ID: 29405237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.